To gain further insight into the biological function of RIPK2 in the development of Taxol resistance in ovarian cancer, the coexpressed genes of RIPK2 in serous ovarian cancer patients treated with Taxol were analyzed. This evidence concerns the gene RIPK2 and ovarian serous adenocarcinoma.